EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study

Takaaki Konuma iD, Naoyuki Uchida, Wataru Takeda, Noriko Doki, Satoshi Yoshihara, Tetsuya Nishida, Takuro Kuriyama, Masatsugu Tanaka, Hiroyuki Ohigashi, Hirohisa Nakamae, Yuta Katayama, Shuichi Ota und 5 weitere

Vox Sanguinis · 2024-06 · 119 (6) · 612-618

DOI: 10.1111/vox.13610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 29.02.2024. Verfasst von Takaaki Konuma und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Registries, Graft vs Host Disease, Rh-Hr Blood-Group System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives ABO blood group mismatch between the donor and the recipient can affect the success of the transplant as well as problems with the red blood cells during allogeneic haematopoietic cell transplantation (HCT). However, the impact of the Rhesus (Rh) D mismatch on transplant outcomes in allogeneic HCT has been poorly elucidated. Materials and Methods We retrospectively evaluated the impact of the RhD mismatch on post‐transplant outcomes in 64,923 patients who underwent allogeneic HCT between 2000 and 2021 using a Japanese registry database.

Results

Out of the whole group, 64,293, 322, 270 and 38 HCTs were done when the recipient or donor was RhD‐mismatched with (+/+), (−/+), (+/−) or (−/−) combinations. The difference in RhD between recipient/donor (−/+), (+/−) and (−/−) did not affect haematopoietic recovery, acute and chronic graft‐versus‐host disease (GVHD), overall survival (OS), non‐relapse mortality (NRM) or relapse when RhD (+/+) was used as the reference group in multivariate analysis.

Conclusion

Our registry‐based study demonstrated that RhD mismatch between recipient and donor did not significantly impact haematopoietic recovery, GVHD, OS, NRM or relapse after allogeneic HCT. These data suggest that RhD mismatches may not need to be avoided for recipient and donor combinations in allogeneic HCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationRegistriesGraft vs Host DiseaseRh-Hr Blood-Group SystemHumansFemaleMaleAdultMiddle AgedJapanRetrospective StudiesAdolescentBlood Group IncompatibilityTransplantation, HomologousChildChild, PreschoolInfantEast Asian People

Stichwörter der Autor:innen

RhD alloimmunizationRhD antigenRhD incompatibilityRhD mismatchallogeneic haematopoietic cell transplantationrhesus

Substanzen

Rh-Hr Blood-Group SystemRho(D) antigen

Autor:innen und Institutionen

  • Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan.
  • Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.

ORCID-Profile: Takaaki Konuma, Fumihiko Ishimaru

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Konuma, T., Uchida, N., Takeda, W., Doki, N., Yoshihara, S., Nishida, T., Kuriyama, T., Tanaka, M., Ohigashi, H., Nakamae, H., Katayama, Y., Ota, S., Hashii, Y., Ishimaru, F., Fukuda, T., Ohbiki, M., & Atsuta, Y. (2024). RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study. Vox Sanguinis, 119(6), 612-618. https://doi.org/10.1111/vox.13610

Vancouver

Konuma T, Uchida N, Takeda W, Doki N, Yoshihara S, Nishida T, et al. RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study. Vox Sanguinis. 2024;119(6):612-618. doi:10.1111/vox.13610

BibTeX
@article{Konuma2024,
  author = {Konuma, Takaaki and Uchida, Naoyuki and Takeda, Wataru and Doki, Noriko and Yoshihara, Satoshi and Nishida, Tetsuya and Kuriyama, Takuro and Tanaka, Masatsugu and Ohigashi, Hiroyuki and Nakamae, Hirohisa and Katayama, Yuta and Ota, Shuichi and Hashii, Yoshiko and Ishimaru, Fumihiko and Fukuda, Takahiro and Ohbiki, Marie and Atsuta, Yoshiko},
  title = {RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study},
  journal = {Vox Sanguinis},
  year = {2024},
  volume = {119},
  number = {6},
  pages = {612--618},
  doi = {10.1111/vox.13610}
}
Kostenlos starten →